SB

Suraj Bhan Sharma

Active Director Director DIN 11263135
DIN 11263135 First appointment Aug 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value •••• Premium profile

About Suraj Bhan Sharma

Data last updated:

Suraj Bhan Sharma is a Director at Hiral Labs Limited (since 2025). The company operates in Pharma. Hiral Labs Limited reported revenue of ₹66.46 Cr (FY 2025).

DIN 11263135
Primary Designation Director
Industry Pharma
First Appointment 28 Aug 2025
Oldest Company Age 26 yrs
Largest company Hiral Labs Limited · ₹66.46 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hiral Labs Limited U24231GJ2000PLC038759
Director28 Aug 20252000₹66.46 Cr (FY 2025)Active

Board colleagues of Suraj Bhan Sharma

Directorship timeline

Open interactive timeline →
Hiral Labs Limited
Premium access

Shareholding and investment profile for Suraj Bhan Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suraj Bhan Sharma

Suraj Bhan Sharma currently holds 1 directorship: Hiral Labs Limited (Director, since 28 Aug 2025, revenue ₹66.46 Cr (FY 2025)).

Suraj Bhan Sharma was first appointed on 28 Aug 2025 as Director at Hiral Labs Limited.

The current boards of Suraj Bhan Sharma's companies include Amit Ramavtar Jajoo (Hiral Labs Limited), Fahed Ali Haider Ali Saiyed (Hiral Labs Limited), Haiderali Munavarli Saiyed (Hiral Labs Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available